24小时热门版块排行榜

返回列表

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

cao2oem

金虫 (著名写手)

应助: 5 (幼儿园)
贵宾: 1.2
金币: 15718.3
散金: 200
红花: 1
帖子: 1462
在线: 299.1小时
虫号: 23408
注册: 2003-09-24
性别: GG
专业: 中药药效物质

[求助] OL拒稿信已有7人参与

投的OL被拒了，两个reviewer的意见是大修，分别给了6，7分，一个直接拒，只给1分。

Thank you for submitting your manuscript for publication in Organic Letters. It has been examined by expert reviewers whose reviews are enclosed. The reviewers have expressed serious reservations about this work that I don’t believe could be addressed through a standard major revision. In light of the comments received, I am unable to accept the manuscript for publication in Organic Letters.

However, if further experimentation, analysis, and revisions allow you to address the referees concerns in full we would be happy to consider within 60 days at the latest a revised new manuscript that revises the current work to include such data and analysis (assuming no related data is published in the interim). This revised new manuscript should address the reviewers’ comments and your cover letter should include a point-by-point response to the concerns. Please note that questions and comments from the reviewers should be regarded as representative of those that might be posed by readers of the article. Consequently, these questions and comments should be addressed not only in the response letter but also within the body of the resubmitted manuscript itself.

NOTE: The resubmitted work will have a new submission date and a new manuscript number.

You will see your manuscript files for this submission in your Paragon Plus account in the Author tab (in the list near the bottom) titled:

"Expired Revisions and Manuscripts No Longer Under Consideration."

This link will remain for 60 days. We can extend the due date upon request. If you have not submitted the work by the due date, the manuscript will no longer appear in your Paragon Plus account, however you can still submit it. In your cover letter, include information about the prior submission and a detailed description of the changes made in response to the points raised in the prior evaluation.

这再投还有意义吗

回复此楼